Navigation Links
Intercell Announces Initiation of Further Phase II Clinical Trial of V710 an Investigational Vaccine to Prevent S. aureus Infection
Date:8/28/2008

us

S. aureus is the most frequent cause of hospital-acquired infections. In addition to bloodstream infections with a mortality rate of up to 35%, infections of bone, heart and other inner organs are leading to serious health complications, death and economic burden. Today, approximately 50% of S. aureus strains isolated in hospitals worldwide are resistant to multiple antibiotics, rendering staphylococcal disease management increasingly difficult and challenging. Hospital-acquired infections are one of the major causes of death and serious illness worldwide, resulting in an annual burden of more than USD 20 billion in the developed world. In the United States alone, about two million patients become infected annually while receiving health care in hospitals.

About Intercell AG

Intercell AG is a growing biotechnology company which focuses on the design and development of novel vaccines for the prevention and treatment of infectious diseases with substantial unmet medical need. The Company develops antigens and adjuvants which are derived from its proprietary technology platforms and has in-house GMP manufacturing capabilities. Based on these technologies, Intercell has strategic partnerships with a number of global pharmaceutical companies, including Novartis, Merck & Co., Inc., Wyeth, Sanofi Pasteur, Kirin, and the Statens Serum Institut.

The Company's leading product, a prophylactic vaccine against Japanese Encephalitis, successfully concluded pivotal Phase III clinical trials in 2006 and is currently in the process of market approval in the US, Europe, Australia and Canada. Market approval in the US, Europe and Australia is expected for the second half of 2008.

The company's broad development pipeline includes a Travelers' Diarrhea vaccine (patch) in Phase II (start of Phase III expected in 2009), a Pseudomonas vaccine in Phase II, as well as an immunostimulant vaccine patch in pandemic Flu, a partnered S. aureus vaccine in Phas
'/>"/>

SOURCE Intercell AG
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Intercell AG to Acquire Iomai Corporation to Expand Late Stage Product Pipeline and Strengthen Leadership in Vaccine Innovation
2. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
3. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
4. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
5. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
6. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
7. Phosphagenics Announces Positive Phase 1b Transdermal Insulin Clinical Trial Results
8. Xenomics Announces Implementation of its First Diagnostic Test for Acute Myeloid Leukemia Into Clinical Practice
9. Emisphere Technologies, Inc. Announces 2007 Second Quarter Financial Results
10. Amicus Therapeutics Announces Second Quarter 2007 Financial Results
11. Genta Incorporated Announces Second Quarter 2007 Financial Results and Corporate Highlights
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/6/2015)... Inc. (Nasdaq: NXTM ), a leading manufacturer of ... that exceed the top end of its guidance range. ... 2015 increased 10 percent to $79.5 million, compared with ... 2014. The Company,s revenue guidance range for the first ... was driven by outperformance in the System One segment ...
(Date:5/6/2015)... Eli Lilly and Company (NYSE: LLY ... delivery and device innovation center in Cambridge, ... help attract top scientists and bioengineers, as well as ... The Lilly Cambridge Innovation Center, a makerspace located in ... organizations to explore how emerging technologies and connectivity can ...
(Date:5/6/2015)... 2015 According to a ... Market by Technology (Precipitation, Dialysis, Electrophoresis, Western Blotting, ... Kits, Reagents, Resins) by Application & End User ...  the global Protein Purification and Isolation Market was ... is expected to reach $ 6,370 Million by ...
Breaking Medicine Technology:NxStage Reports First Quarter 2015 Financial Results And Exceeds Guidance 2NxStage Reports First Quarter 2015 Financial Results And Exceeds Guidance 3NxStage Reports First Quarter 2015 Financial Results And Exceeds Guidance 4NxStage Reports First Quarter 2015 Financial Results And Exceeds Guidance 5NxStage Reports First Quarter 2015 Financial Results And Exceeds Guidance 6NxStage Reports First Quarter 2015 Financial Results And Exceeds Guidance 7NxStage Reports First Quarter 2015 Financial Results And Exceeds Guidance 8NxStage Reports First Quarter 2015 Financial Results And Exceeds Guidance 9NxStage Reports First Quarter 2015 Financial Results And Exceeds Guidance 10NxStage Reports First Quarter 2015 Financial Results And Exceeds Guidance 11Eli Lilly and Company Reveals Plan for Innovation Center in Cambridge, Massachusetts 2Eli Lilly and Company Reveals Plan for Innovation Center in Cambridge, Massachusetts 3Protein Purification and Isolation Market Worth $6,370 Million by 2020 2Protein Purification and Isolation Market Worth $6,370 Million by 2020 3Protein Purification and Isolation Market Worth $6,370 Million by 2020 4
... LAKES, N.J. and MONTREAL, Oct. 13, 2011 A ... gene testing analysis found that 38 percent of patients ... clots, heart attack and stroke—were also using another drug ... http://photos.prnewswire.com/prnh/20100609/MEDCOLOGO ) The analysis also showed that ...
... (NYSE AMEX: ULU ), announced today that it has ... company based in Switzerland, to license Altrazeal® for the European Union. ... the European Union rights to a subsidiary of Melmed Holdings AG ... for the license ULURU will receive a licensing payment and a ...
Cached Medicine Technology:Putting Gene Tests to Use: More Than a Third of Patients Cannot Properly Metabolize Plavix® 2Putting Gene Tests to Use: More Than a Third of Patients Cannot Properly Metabolize Plavix® 3Putting Gene Tests to Use: More Than a Third of Patients Cannot Properly Metabolize Plavix® 4ULURU Inc. Announces Altrazeal® Agreement for the European Market 2ULURU Inc. Announces Altrazeal® Agreement for the European Market 3
(Date:5/6/2015)... San Mateo, Calif. (PRWEB) May 06, 2015 ... SafeMonk today announced a strategic partnership to ... in the cloud. The two industry-leading companies are teaming ... encryption platform. , “We’re thrilled to welcome ... meaningful to us that the people behind SafeMonk, the ...
(Date:5/6/2015)... Canadian, OK (PRWEB) May 06, 2015 ... Occupational Health (FOH) agency, operating within the U.S. Department ... of May as National Physical Fitness and Sports Month. ... active living and its importance to health. Throughout ... active, eat well, and get fit. , The HHS ...
(Date:5/6/2015)... 06, 2015 Most people in the United ... or other care after age 65. But less than half ... it or even talking about it, reports the May 2015 ... risk two problems. One is losing control over the care ... says Dr. David Grabowski, a professor of health care policy ...
(Date:5/6/2015)... 06, 2015 The Center for Innovative ... has invested in e-Kare, Inc. of Fairfax, VA, a ... monitoring of chronic wounds. , Chronic wounds include pressure, ... wounds that affect over 6.5 million U.S. patients, costing ... spin-off enterprise from the Children’s National Medical Center (CNMC), ...
(Date:5/6/2015)... May 06, 2015 Spiking drug prices are ... a new survey by The Senior Citizens League ... report higher co-pays and co-insurance costs than expected in 2014 ... for the cost spikes may be tough for many beneficiaries ... high drug prices are commonly associated with brand and newer ...
Breaking Medicine News(10 mins):Health News:Sookasa Grows Globally With SafeMonk Partnership 2Health News:Sookasa Grows Globally With SafeMonk Partnership 3Health News:Narconon Arrowhead Issues Guide for Physical Fitness and Sports Month 2Health News:Narconon Arrowhead Issues Guide for Physical Fitness and Sports Month 3Health News:Start Planning Now for Long-Term Care, from the May 2015 Harvard Health Letter 2Health News:CIT GAP Funds Invests in e-Kare 2Health News:CIT GAP Funds Invests in e-Kare 3Health News:New Survey By The Senior Citizens League Reveals 61% Had Higher Than Expected Medicare Part D Costs In 2014 2Health News:New Survey By The Senior Citizens League Reveals 61% Had Higher Than Expected Medicare Part D Costs In 2014 3
... 2, 2009) New research published in the February issue ... shows a warm-up of 15 to 20 minutes with ... substantial increase in proficiency of surgical skills in surgeons of ... both psychomotor and cognitive skills raises surgeons, alertness to a ...
... (NYSE: WTW ) will release its results for ... close on Wednesday, March 4, 2009.The Company has also scheduled ... During the conference call, David Kirchhoff, President and Chief Executive ... quarter and full year results and answer questions from the ...
... /PRNewswire/ -- Kirby Lester, LLC, the world,s ... automated technology breakthrough: the KL30 automated dispensing and ... sized and priced for any retail pharmacy or hospital ... per day.Kirby Lester introduced the KL30 today at the ...
... CHICAGO, Feb. 2 The American Dietetic Association will pursue ... and recommend to Congress that a primary goal of new ... of our citizens should improve as a result of our ... M. Yadrick. "Nutrition needs to rise as a national priority, ...
... Meet in Boise, Idaho, Feb. 7-13 to Promote Acceptance ... World ATLANTA, Feb. 2 Wesley Mosley from ... from around the world to participate in the fifth ... be held in conjunction with the 2009 Special Olympics ...
... CarePHOENIX, Feb. 2 In celebration of American ... Annual Public Forum showcasing a live- telecast ... blood vessel disease on Tuesday, February 10, 2009. ... Founder and Medical Director of Arizona Heart Institute ...
Cached Medicine News:Health News:Journal of American College of Surgeons study finds warm-up helps surgeons improve performance 2Health News:Weight Watchers Announces Fourth Quarter and Full Year 2008 Earnings Conference Call 2Health News:Kirby Lester's New KL30: Fully Automated, Compact System for a Fraction of the Cost of a Robotic Dispenser 2Health News:Kirby Lester's New KL30: Fully Automated, Compact System for a Fraction of the Cost of a Robotic Dispenser 3Health News:American Dietetic Association Announces Agenda for Health Reform 2Health News:Wesley Mosley Selected to Participate in Global Youth Activation Summit During the 2009 Special Olympics World Winter Games 2Health News:Wesley Mosley Selected to Participate in Global Youth Activation Summit During the 2009 Special Olympics World Winter Games 3Health News:Arizona Heart Institute Announces FREE Public Forum Featuring Live Viewing of Surgical Procedures Via High-Definition (HD) Satellite 2
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
Medicine Products: